D. Jenny Xiradakis
FDA investigator
Appears on 1 document from 2014, mostly at sites in New York. Most often cites design and construction features (21 CFR 211.42).
- 1
- Documents on file
- 13.0
- Observations per 483
- 2014
- First seen
- 2014
- Most recent
What they cite most
From 13 observations- 21 CFR 211.42Design and construction features4
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.130Packaging and labeling operations1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.167Special testing requirements1
- 21 CFR 211.192Production record review1
Activity by year
2014: 1
Where
New York 1
Often inspects with
Is D. Jenny Xiradakis coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2014-04-23 | 483 Infusion Options, Inc.Apr 23, 2014 · Brooklyn, New York | Brooklyn, New York | 13 |
About this profile
What does D. Jenny Xiradakis inspect?
D. Jenny Xiradakis appears on 1 document on file covering 1 site, mostly in New York.
What do they cite most often?
21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.130.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for D. Jenny Xiradakis is dated Apr 23, 2014.